ArdeoGraft
Commercial- Indications
- Wound care, Surgical applications
Company intelligence / Profile preview
Surgenex is a leading biotechnology company specializing in the development, manufacturing, and commercialization of human cellular and tissue-based products. Its proprietary Excellion® process produces high-quality amniotic membrane allografts for use in orthopaedics, sports medicine, podiatry, pain management, joint care, ophthalmology, and reconstructive dentistry. The company operates under stringent quality standards exceeding FDA/AATB requirements. Products are commercially available; no clinical trial results are published as these are regulated as HCT/Ps rather than drugs or biologics.
5 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Surgenex.